Piramal Pharma Ltd (NSE: PPLPHARMA) Q3 2026 Earnings Call dated Jan. 29, 2026 Corporate Participants: Gagan Borana — Head Investor Relations Peter DeYoung — Chief Excutive Officer Nandini Piramal — Chair Person Vivek Valsaraj — President and Chief Financial Officer Analysts: Tushar Manudane — Analyst Abdul Kadar Puranwala — Analyst Madhav — Analyst Parikshit Gupta […]
Piramal Pharma Ltd (NSE: PPLPHARMA), a leading global pharmaceutical and life sciences company headquartered in Mumbai, reported its financial results for the third quarter (Q3) of the fiscal year ending December 31, 2025, on January 29, 2026. The quarter’s performance reflects a mix of operational challenges alongside areas of resilient execution, underscoring the cyclical nature […]
Piramal Finance Limited (NSE: PEL) Q3 2026 Earnings Call dated Jan. 23, 2026 Corporate Participants: Unidentified Speaker Anand Piramal — Executive Director Jairam Sridharan — Chief Executive Officer of Retail Financing Business Yesh Nadkarni — Chief Executive Officer of Wholesale Lending Vikash Singhla — Chief Executive Officer Analysts: Unidentified Participant Avinash Singh — Analyst Abhijit […]
Piramal Finance Ltd (NSE: PEL) closed at ₹1,822.10, higher on the day at the market close following the release of its third‑quarter financial results. Market capitalization Market capitalization stood at approximately ₹40,664 crore at the close. Latest quarterly results (Q3 FY26) • Consolidated revenue for the quarter was ₹1,480 crore, up 29% year over year. […]
Piramal Enterprises Ltd (NSE: PEL) Q2 2025 Earnings Call dated Oct. 23, 2024 Corporate Participants: Ravi Singh — Head, Investor Relations and Sustainability Ajay Piramal — Chairman, Piramal Group Jairam Sridharan — CEO, Retail Lending and MD, Piramal Capital and Housing Finance Limited (PCHFL) Yesh Nadkarni — Chief Executive Officer, Wholesale Lending Upma Goel — […]
Piramal Enterprises Ltd (NSE: PEL) Q3 2025 Earnings Call dated Jan. 27, 2025 Corporate Participants: Ajay Piramal — Chairman Jairam Sridharan — Managing Director, Piramal Capital & Housing Finance Limited (PCHFL) Upma Goel — Chief Financial Officer Unidentified Speaker Analysts: Avinash Singh — Analyst Shubhranshu Mishra — Analyst Kunal Shah — Analyst Abhijit Tibrewal — […]
Piramal Enterprises Ltd (NSE: PEL) Q4 2025 Earnings Call dated May. 06, 2025 Corporate Participants: Unidentified Speaker Ajay Piramal — Chairman and Executive Director Jairam Sridharan — Chief Executive Officer of Retail Financing Business Upma Goel — Chief Financial Officer Yeshwant Ramchandra Nadkarni — Chief Executive officer, Wholesale Lending Analysts: Unidentified Participant Shreya Shivani — […]
Piramal Enterprises Ltd (NSE: PEL) Q1 2026 Earnings Call dated Jul. 29, 2025 Corporate Participants: Unidentified Speaker Ajay Piramal — Chairman Jairam Sridharan — Chief Executive Officer of Retail Financing Business Yeshwant Ramchandra Nadkarni — Chief Executive officer, Wholesale Lending Upma Goel — Chief Financial Officer Analysts: Unidentified Participant Abhijit Tibrewal — Analyst Shubhranshu Mishra […]
Piramal Pharma Ltd (NSE: PPLPHARMA) Q2 2025 Earnings Call dated Oct. 24, 2024 Corporate Participants: Gagan Borana — Head Investor Relations Nandini Piramal — Chairperson Vivek Valsaraj — Chief Financial Officer Peter DeYoung — Chief Executive Officer – Global Pharma Analysts: Vinod Jain — Analyst Yasser — Analyst Gopinath — Analyst Yash Darak — Analyst […]
Piramal Pharma Ltd (NSE: PPLPHARMA) Q3 2025 Earnings Call dated Jan. 29, 2025 Corporate Participants: Gagan Borana — Head Investor Relations & Enterprise Risk Management Nandini Piramal — Chairperson Vivek Valsaraj — President & Chief Financial Officer Peter DeYoung — Chief Executive Officer, Piramal Global Pharma, Piramal Pharma Ltd. Analysts: Amey Chalke — Analyst Sudarshan […]